Harbor Investment Advisory’s AstraZeneca AZN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $221K | Buy |
3,167
+134
| +4% | +$9.36K | 0.02% | 355 |
|
|
2025
Q1 | $223K | Buy |
3,033
+368
| +14% | +$27K | 0.02% | 356 |
|
|
2024
Q4 | $175K | Buy |
2,665
+712
| +36% | +$46.7K | 0.02% | 372 |
|
|
2024
Q3 | $152K | Sell |
1,953
-68
| -3% | -$5.3K | 0.02% | 377 |
|
|
2024
Q2 | $158K | Buy |
2,021
+587
| +41% | +$45.8K | 0.02% | 372 |
|
|
2024
Q1 | $97.2K | Buy |
1,434
+643
| +81% | +$43.6K | 0.01% | 452 |
|
|
2023
Q4 | $53.3K | Buy |
791
+416
| +111% | +$28K | 0.01% | 557 |
|
|
2023
Q3 | $25.4K | Buy |
375
+19
| +5% | +$1.29K | ﹤0.01% | 656 |
|
|
2023
Q2 | $25.5K | Buy |
356
+10
| +3% | +$716 | ﹤0.01% | 856 |
|
|
2023
Q1 | $24K | Hold |
346
| – | – | ﹤0.01% | 881 |
|
|
2022
Q4 | $23.5K | Sell |
346
-4
| -1% | -$271 | ﹤0.01% | 872 |
|
|
2022
Q3 | $19K | Hold |
350
| – | – | ﹤0.01% | 916 |
|
|
2022
Q2 | $23K | Hold |
350
| – | – | ﹤0.01% | 874 |
|
|
2022
Q1 | $23K | Hold |
350
| – | – | ﹤0.01% | 908 |
|
|
2021
Q4 | $20K | Buy |
350
+4
| +1% | +$229 | ﹤0.01% | 927 |
|
|
2021
Q3 | $21K | Hold |
346
| – | – | ﹤0.01% | 927 |
|
|
2021
Q2 | $21K | Hold |
346
| – | – | ﹤0.01% | 888 |
|
|
2021
Q1 | $17K | Hold |
346
| – | – | ﹤0.01% | 895 |
|
|
2020
Q4 | $17K | Buy |
346
+110
| +47% | +$5.41K | ﹤0.01% | 844 |
|
|
2020
Q3 | $13K | Hold |
236
| – | – | ﹤0.01% | 806 |
|
|
2020
Q2 | $12K | Hold |
236
| – | – | ﹤0.01% | 736 |
|
|
2020
Q1 | $11K | Hold |
236
| – | – | ﹤0.01% | 709 |
|
|
2019
Q4 | $12K | Buy |
+236
| New | +$12K | ﹤0.01% | 597 |
|